Wong Roderick
SEC-identified person · CIK 1493280 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Orchestra Biomed Holdings, Inc. OBIO | Director · Chief Executive Officer | filed 2020 - 2026 |
| Kailera Therapeutics, Inc. KLRA | Officer | filed 2026 - 2026 |
| Allurion Technologies, INC. ALUR | Director | filed 2025 - 2025 |
| Rocket Pharmaceuticals, INC. RCKT | Director | filed 2018 - 2025 |
| Cargo Therapeutics, Inc. CRGX | Officer | filed 2023 - 2024 |
| Renovacor, Inc. RCOR | Officer | filed 2021 - 2023 |
| Milestone Pharmaceuticals Inc. MIST | Officer | filed 2019 - 2023 |
| Dermtech, Inc. DMTK | Officer | filed 2019 - 2022 |
| Landos Biopharma, Inc. LABP | Director | filed 2021 - 2022 |
| Avidity Biosciences, Inc. RNAM | Director · MP and CIO | filed 2020 - 2021 |
| Tarsus Pharmaceuticals, Inc. TARS | Officer | filed 2020 - 2021 |
| Prometheus Biosciences, Inc. RXDX | Officer | filed 2021 - 2021 |
| Leonabio, Inc. LONA | Officer | filed 2020 - 2020 |
| Tela Bio, Inc. TELA | Officer | filed 2019 - 2019 |
| Immunovant, Inc. IMVT | Director · President and CEO | filed 2019 - 2019 |
| Stoke Therapeutics, Inc. STOK | Officer | filed 2019 - 2019 |
| Penwest Pharmaceuticals CO PPCO | Director | filed 2010 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.